Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care

These appointments reflect Zimmer Biomet's commitment to deepening clinical collaboration and accelerating advancements across the portfolio

Zimmer Biomet Holdings, a global medical technology leader, announced the appointments of Jonathan M. Vigdorchik, MD, as Chief Medical Technology Advisor focused on Adult Reconstruction and Hip Implants, and Anand M. Murthi, MD, FAAOS, as Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma (S.E.T.). As strategic advisors, Drs. Vigdorchik and Murthi will leverage their extensive clinical experience to help guide the Company's new product pipeline and portfolio strategy across their respective areas of focus and enhance Zimmer Biomet's medical education initiatives.

Dr. Vigdorchik is a board-certified, fellowship-trained orthopaedic surgeon at Hospital for Special Surgery (HSS) in New York City, specialising in hip and knee replacement surgery. Dr. Murthi is a board-certified, fellowship-trained orthopaedic surgeon who serves as Chief of Shoulder and Elbow Surgery and Director of the Shoulder and Elbow Fellowship Program at MedStar Union Memorial Hospital in Baltimore, Md.

"These appointments reflect Zimmer Biomet's commitment to deepening clinical collaboration and accelerating advancements across our portfolio – from implants and robotic technology to sports medicine and extremities," said Ivan Tornos, Chairman, President and Chief Executive Officer, Zimmer Biomet. "We're proud to welcome them both as strategic partners in helping to redefine the future of musculoskeletal care."

In these roles, Drs. Vigdorchik and Murthi will assist with our medical education and surgeon engagement; advise on the Company's technology and implant strategy and development roadmap; and serve as strategic liaisons between Zimmer Biomet and the broader surgical community.